Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Impaired wound healing: CD47’s latest safety hurdle?

New study adds wound healing problems to list of AEs CD47 companies need to monitor

Just as anti-CD47 antibodies are getting past their first safety hurdle of hematological toxicities, a new study has cautioned that the antibodies could have a dangerous effect on wound healing.

In a paper published in Nature Communications on Nov. 1, a team led by University of

Read the full 461 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers